RezkallaSHKlonerRA. Coronary no-reflow phenomenon: from the experimental laboratory to the cardiac catheterization laboratory. Catheter Cardiovasc Interv. 2008; 72: 950–957.
2.
EeckhoutEKernMJ. The coronary no-reflow phenomenon: a review of mechanisms and therapies. Eur Heart J. 2001; 22:729–739.
3.
NdrepepaGTirochKFusaroM, et al.5-Year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. Journal of American College of Cardiology. 2010; 55:2383–9.
4.
BroshDAssaliARMagerA, et al.Effect of no-reflow during primary percutaneous coronary intervention for acute myocardial infarction on six-month mortality. Am J Cardiol. 2007; 99:442–445.
5.
WuKCZerhouniEAJuddRM, et al.Prognostic significance of microvascular obstruction by magnetic resonance imaging in patients with acute myocardial infarction. Circulation. 1998; 97: 765–772.
6.
ItoH. No-reflow phenomenon and prognosis in patients with acute myocardial infarction. Nature Clinical Practice of Cardiovascular Medicine. 2006; 3: 499–506.
7.
KotaniJNantoSMintzGSKitakazeMOharaTMorozumiTNagataSHoriM. Plaque gruel of atheromatous coronary lesion may contribute to the no-reflow phenomenon in patients with acute coronary syndrome. Circulation. 2002; 106:1672–1677.
8.
NiccoliGLanzaGASpazianiC, et al.Baseline systemic inflammatory status and no-reflow phenomenon after percutaneous coronary angioplasty for acute myocardial infarction. International Journal of Cardiology. 2007; 117:306–311.
9.
CostaFvan KlaverenDJamesSHegDRäberLFeresFPilgrimTHongMKKimHSColomboA, et al.; PRECISE-DAPT Study Investigators. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials. Lancet. 2017; 389:1025–1034.
10.
ValgimigliMBuenoHByrneRAColletJPCostaFJeppssonAJüniPKastratiAKolhPMauriL, et al.; ESC Scientific Document Group; ESC Committee for Practice Guidelines (CPG); ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the task force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2018; 39:213–260.
11.
SelçukMÇınarTŞaylıkFDemirozOYıldırımE. The Association of a PRECISE-DAPT Score with No-reflow in Patients with ST-Segment Elevation Myocardial Infarction. Angiology. 2021. details to be added when pagination is available
